Global RNAi-Based Biocontrol Products Market Set for Strong Growth as Sustainable Agriculture Accelerates: Forecast to Reach US$ 232 Million by 2032
Global Leading Market Research Publisher QYResearch announces the release of its latest report “RNAi-Based Biocontrol Products – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global RNAi-Based Biocontrol Products market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global RNAi-Based Biocontrol Products market is gaining momentum as agricultural systems shift toward precision, sustainability, and low-residue crop protection solutions. Driven by increasing pest resistance to conventional chemicals and stricter environmental regulations, RNA interference (RNAi)-based technologies are emerging as a next-generation biological control platform. These products offer targeted gene silencing mechanisms that reduce crop damage while minimizing impact on non-target organisms, positioning them as a key innovation in the global market analysis, industry development, and agricultural biotechnology outlook.
Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6259114/rnai-based-biocontrol-products
The global RNAi-Based Biocontrol Products market was valued at US$ 137 million in 2025 and is projected to reach US$ 232 million by 2032, growing at a CAGR of 7.7% from 2026 to 2032. This steady expansion reflects rising global adoption of RNAi-driven solutions within Integrated Pest Management (IPM) systems, increasing investment in sustainable agriculture technologies, and growing demand for environmentally safe crop protection alternatives. From a market size and market share perspective, early commercialization is currently concentrated among a limited number of biotechnology innovators, but competitive participation is expected to broaden as regulatory frameworks mature and production costs decline.
RNAi-based biocontrol products function through RNA interference (RNAi), a biological mechanism that silences essential genes in target pests or pathogens, effectively disrupting their survival and reproduction. Commercial development follows two primary pathways: PIP (Plant-Incorporated Protectants), where crops are engineered to express protective RNA internally, and Non-PIP formulations, where dsRNA or short RNA molecules are applied externally through foliar sprays, soil treatments, or chemigation systems.
From a market research and industry structure perspective, the RNAi biocontrol value chain is highly technology-intensive. Upstream components include nucleotide synthesis, enzyme systems, fermentation-based production, and in vitro transcription technologies. Formulation innovation plays a critical role, including encapsulation systems, controlled-release carriers, UV protection agents, rainfast stabilizers, and uptake enhancers. Downstream demand is driven by crop protection companies, seed developers, large-scale agricultural producers, distributors, and public agricultural programs.
Applications cover a wide spectrum, including farmland crops, orchards, and protected horticulture systems. These products are increasingly integrated into resistance management programs and IPM strategies, often used in rotation with conventional chemical pesticides or other biological inputs to enhance durability and reduce resistance pressure.
A key industry development and market trend is the transition from laboratory validation to scalable commercial deployment. Non-PIP sprayable formulations are currently leading early market adoption due to more flexible regulatory pathways, while PIP-based solutions are progressing through longer development cycles tied to trait approval and seed commercialization. Market performance is highly dependent on field delivery efficiency, environmental stability, and cost-effective manufacturing scalability.
On a manufacturing basis, gross margins typically range between 30% and 50%, influenced by production methods, formulation complexity, quality control standards, and distribution models. However, long-term profitability will depend on cost reduction in large-scale production, improvements in field persistence, and harmonization of regulatory approval timelines across regions.
Looking forward, the industry outlook and market forecast indicate that RNAi-based biocontrol products will increasingly become part of mainstream agricultural input systems. Key growth drivers include rising global food demand, tightening environmental regulations, increasing resistance to traditional pesticides, and rapid advancements in biomanufacturing and delivery technologies. At the same time, challenges remain in ensuring consistent field performance, improving product stability under environmental stress, and navigating diverse regulatory frameworks.
RNAi-Based Biocontrol Products Market Segmentation
Leading Companies:
Bayer
Corteva
Greenlight Biosciences
RNAissance Ag
Pebble Labs
Renaissance BioScience
Silicon Gene
Shanghai Plant Science Biotechnology
Xiaomo Biotech
Segment by Type:
- PIP
- Non-PIP
Segment by Application:
- Farmland
- Orchard
- Other
The competitive landscape is expected to evolve as more biotechnology firms enter the space, with increasing collaboration between agrochemical leaders and RNA technology developers to accelerate commercialization and global expansion.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
